Nanoparticle Vaccine Could Curb Cancer Metastasis to Lungs Through Protein Targeting
|
In a study led by Moores Member Nicole Steinmetz, Ph.D., UC San Diego researchers have developed a new vaccine that could prevent the spread of metastatic cancer to the lungs by targeting the tumor microenvironment. Learn More
|
| |
2023 Moores Annual Scientific Retreat
|
November 14, 2023 | Scripps Seaside Forum
|
This year’s program will include a special presentation by Dr. John Carethers, Distinguished Professor of Medicine and Vice Chancellor for Health Sciences and a keynote address by Dr. Cheryl Anderson, Professor and Dean of the Herbert Wertheim School of Public Health and Human Longevity Science. Register Now
|
Elena Martinez, Ph.D., M.P.H. Awarded the UChicago Medicine 2023 Simon M. Shubitz Cancer Prize and Lectureship
|
This prize has recognized internationally respected scientists who have made substantial contributions to the study of cancer since 1978. As this year's recipient, Moores Member and Associate Director for Population Science, Disparities, and Community Engagement, Dr. Elena Martinez, will present her lecture Journey Through a Remarkable Career Driven by Curiosity and Exceptional Mentoring at the University of Chicago Knapp Center for Biomedical Discovery. Learn More
|
|
|
October 24, 2023 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons
|
October 25, 2023 | 12:00 p.m. to 1:00 p.m.
Moores Comer Commons
|
October 31, 2023 | 12:00 p.m.
Leichtag Biomedical Research Building Room 107
|
February 9 & 10, 2023
UC San Diego Park & Market
|
|
|
Applications Now Open for 2024–2025 GloCal Health Fellowship
|
The UC Global Health Institute GloCal Health Fellowship is a 12-month, mentored research fellowship that provides aspiring global health researchers with interdisciplinary education and training in innovative research designed to improve health for populations around the world.
|
UC San Diego Division of Graduate Education and Postdoctoral Affairs Postdoctober Fest 2023
|
Postdoctoberfest is UC San Diego’s month-long celebration of its postdocs to recognize the valuable contributions they make to research, the campus, and society. Click the button below to learn more about the Postdoctober events taking place this month, which include a GEPA sponsored pizza party.
|
NCI Intramural Continuing Umbrella of Research Experiences (iCURE)
|
iCURE recruits cohorts of students and scientists from diverse backgrounds and supports a multidisciplinary mentored research experience at NCI by providing 2-year awards for postbaccalaureates and graduate students and 3-year awards for postdoctoral fellows.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
For 2024, the ALSF Crazy 8 Initiative will target childhood cancer predisposition and prevention. This $3–5 million award over 4 years enables an investigator to assemble a team to improve outcomes for children with cancer and their families. A letter of intent (LOI) is required for consideration to submit a full proposal. Learn More
LOI Deadline: January 4, 2024 at 8:00 p.m. ET
|
These awards fund biomedical research to better understand the causes of pediatric cancers and advance their prevention, treatment, and cure. St. Baldrick's funding priorities comprise new discovery, translational research and early-phase clinical trials, Phase III trials/infrastructure (not this submission cycle), and education of new pediatric oncology researchers.
Deadline: October 31, 2023 at 5:00 p.m.
|
2023 Moores Pre-Award and Grant Development Services, Processes, and Timelines
|
Pre-Award Services and Access
The services below are provided for faculty/grants in the Moores space:
|
- Uploading proposal documents to internal and external submission systems
- Providing review of the application for completion
- Preparing budgets and budget justifications
- Facilitating adherence to checklists and timelines
- Placing proposal in the submission queue
- Serve as liaison between PI and OCGA/HSSPPO
- Assistance with just-in-time (JIT) request
|
Grant Development Services and Access
The services below are provided for all Moores Members, based on priority:
|
- Reserving or requesting services
- Identifying funding opportunities
-
Providing templates and examples of proposal documents
- Providing scientific review and/or meticulous editing of proposal documents
- Crafting supporting documents (e.g., letters of support, facilities, etc.), formatting/editing biosketches, and rendering documents (e.g., abstracts) readable for lay audiences
|
|
|
Journal of the American Chemical Society
William H. Fenical, Ph.D. (Solid Tumor Therapeutics)
|
Nature Communications
Bing Ren, Ph.D. (Structural and Functional Genomics)
|
The Journal of Clinical Investigation
Pradipta Ghosh, M.D. (Cancer Biology and Signaling)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
NRG-HN009: Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 mg/m2) Every 3 Weeks versus Radiation with Low-Dose Weekly Cisplatin (40 mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
|
PI: Loren K. Mell, M.D.
NCT: NCT05050162
|
COVALENT-102: A Phase I/Ib Dose Finding Study of BMF219, an Oral Covalent Menin Inhibitor, in Adult Patients with Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer (PDAC), and Colorectal Cancer (CRC)
|
PI: Sandip P. Patel, M.D.
NCT: NCT05631574
|
|
|
CTO TRANSFORMATION INITIATIVE |
-
Net-new Data Coordinator and Long-Term Follow-Up Coordinator roles have been posted to enable our CRCs to focus on patient accruals and treatment. We encourage you to discuss these positions with CTO Leadership and apply if either of these roles align with your unique skillsets and interests.
-
Over 150 participants attended the Staff CTO Town Hall on Tuesday, October 17, 2023 to celebrate the CTO successes and provide updates on the progress of the transformation. CTO hopes that participants found the session valuable and had their questions answered.
-
Fifty-one trials have entered Fast Lane, 11 of which have been activated to date across the Lung, Breast, GU, Gyn, H&N, BMT, Skin, and ET disease teams. CTO thanks the cross-functional teams across UC San Diego for their outstanding efforts to prioritize these high-priority trials for Moores patients.
-
Several new process changes and technology improvements have been initiated. As of Tuesday, October 17, the PRMS Balanced Scorecard is being used to evaluate incoming protocols against Moores strategic priorities. A retrospective review of the active portfolio against the Balanced Scorecard is ongoing, with over 21 reviews submitted to date by several disease teams. An IS Prioritization Committee has been established to prioritize strategic technology initiatives generated at CTO. CTO thanks all PMs and members of the Process and Technology workstreams for their support of these initiatives.
- CTO encourages you to continue to work with your managers and share your feedback, as it helps inform future communications and upcoming Town Hall topics.
|
|
|
EQUITY, DIVERSITY, AND INCLUSION (EDI)
|
NCI Embracing the Complexity: Transdisciplinary Approaches to Advance the Science of Health Disparities Ideation Minilabs
|
Participants can learn what a future in health disparities research should look like—and more importantly—take a deeper dive into what it will take to get there.
|
Mentoring at the CHER Institute 2024 and Fall Webinars 2023
|
The Center for Health Equity Research (CHER) at California State University Long Beach promotes health equity by engaging researchers and community partners in conducting rigorous and innovative public health research. CHER offers a virtual 6-day summer institute and webinar series, along with two extended mentoring programs: CHER Scholars and CHER Champions. Please click the button below to learn more.
|
Predictive Modeling in Biology and Medicine Conference
|
November 17–19, 2023 | University of California, Riverside
|
The conference will address recent progress in mathematical and computational modeling of biological systems, model translational predictions in biology and medicine, and data-driven and machine learning methodologies in biology. The conference will bring together researchers and work to promote interdisciplinary collaborations and diversity, equity, and inclusion (DEI). A special sub-workshop on the development of DEI in education and research will be held on the first day of the conference, November 17, 2023.
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
|
|
Liver Cancer in San Diego Summit
|
Saturday, October 28, 2023 | UC San Diego Park & Market
|
Join UC San Diego Moores Cancer Center clinicians and COE for their inaugural Liver Cancer Awareness Summit. This free 1.5 CME will highlight the current landscape of liver cancer and explore innovative approaches to diagnosis, treatment, and patient support.
This summit is open to healthcare professionals who care for patients at risk of developing liver disease or cancer and seek to enhance their effectiveness in working with patients to reduce the burden of liver cancer.
|
Breast Cancer Awareness Workshop
|
Thursday, October 26, 2023 | 6:00 p.m. to 7:00 p.m.
Border View YMCA | 3601 Arey Drive, San Diego, CA 92154
|
COE and Every Woman Counts will host a special workshop on breast cancer awareness in the Hispanic/Latine community. This workshop is open to all and will teach community members about the signs and symptoms of breast cancer, its impact on the Hispanic/Latine community, and the important steps they can take today to prioritize health.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
3855 Health Sciences Drive MC 0698 | La Jolla, CA 92093 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
|
|
|
